Survivors of childhood cancer have 8.4 times higher risk of mortality

October 2008
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p40
The article discusses research being done on mortality risk in survivors of childhood cancer. It references a study published in a 2008 issue of the "Journal of the National Cancer Institute." The researchers found that mortality was 8.4 times higher for survivors than age-, sex- and year-matched controls. Standardized mortality ratios were highest for survivors of non-acute lymphoblastic leukemia, non-acute myeloid leukemia, primitive neuroectodermal tumor or other central nervous system malignancies and Ewing's sarcoma, according to the findings.


Related Articles

  • Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study. Armstrong, Gregory T.; Qi Liu; Yasui, Yutaka; Huang, Suluan; Ness, Kirsten K.; Leisenring, Wendy; Hudson, Melissa M.; Donaldson, Sarah S.; King, Allison A.; Stovall, Marilyn; Krull, Kevin R.; Robison, Leslie L.; Packer, Roger J. // JNCI: Journal of the National Cancer Institute;7/1/2009, Vol. 101 Issue 13, p946 

    Adult survivors of childhood central nervous system (CNS) malignancies are at high risk for long-term morbidity and late mortality. However, patterns of late mortality, the long-term risks of subsequent neoplasms and debilitating medical conditions, and sociodemographic outcomes have not been...

  • Risk of leukaemia or cancer in the central nervous system among children living in an area with high indoor radon concentrations: results from a cohort study in Norway. Del Risco Kollerud, R; Blaasaas, K G; Claussen, B // British Journal of Cancer;9/23/2014, Vol. 111 Issue 7, p1413 

    Background:Over the past few years, there has been growing interest in assessing the relationship between exposure to radon at home and the risk of childhood cancer. Previous studies have produced conflicting results, probably because of limitations assessing radon exposure, too few cancer cases...

  • Trends in incidence of childhood cancer in Australia, 1983–2006. Baade, P. D.; Youlden, D. R.; Valery, P. C.; Hassall, T.; Ward, L.; Green, A. C.; Aitken, J. F. // British Journal of Cancer;2/10/2010, Vol. 102 Issue 3, p620 

    Background:There are few population-based childhood cancer registries in the world containing stage and treatment data.Methods:Data from the population-based Australian Paediatric Cancer Registry were used to calculate incidence rates during the most recent 10-year period (1997–2006) and...

  • Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer. Danese, Mark D.; Lindquist, Karla; Doan, Justin; Lalla, Deepa; Brammer, Melissa; Griffiths, Robert I. // Journal of Cancer Epidemiology;2012, p1 

    Background. Trastuzumab improves survival in HER2-positive women with metastatic breast cancer (MBC). The consequences of longer survival include a higher likelihood of additional metastases, including those in the central nervous system (CNS). The effect of CNS metastases on both trastuzumab...

  • Recognition of Common Childhood Malignancies. Young, Guy; Toretsky, Jeffrey A.; Campbell, Andrew B.; Eskenazi, Allen E. // American Family Physician;4/1/2000, Vol. 61 Issue 7, p2144 

    Discusses about childhood cancers. Difficulties in diagnosis; Information about leukemia; Details on central nervous system tumors.

  • Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era. Caffo, Orazio; Gernone, Angela; Ortega, Cinzia; Sava, Teodoro; Cartenì, Giacomo; Facchini, Gaetano; Re, Giovanni; Amadio, Placido; Bortolus, Roberto; Pagliarulo, Vincenzo; Prati, Veronica; Veccia, Antonello; Galligioni, Enzo // Journal of Neuro-Oncology;Mar2012, Vol. 107 Issue 1, p191 

    Central nervous system (brain or leptomeningeal) metastases (BLm) are considered rare in castration-resistant prostate cancer (CRPC) patients. Now that docetaxel has become the reference drug for first-line treatment of CRPC, patients whose disease is not controlled by hormonal manipulations may...

  • Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer. Bo-lin Liu; Shu-juan Liu; Baskys, Andrius; Hong Cheng; Ying Han; Chao Xie; Hui Song; Jia Li; Xiao-yan Xin // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background To characterize prognostic and risk factors of central nervous system (CNS) metastases in patients with epithelial ovarian cancer (EOC). Methods A retrospective analysis of Xijing Hospital electronic medical records was conducted to identify patients with pathologically confirmed EOC...

  • Familial syndromes associated with intracranial tumours: a review. Ranger, Adrianna; Patel, Yatri; Chaudhary, Navjot; Anantha, Ram // Child's Nervous System;Jan2014, Vol. 30 Issue 1, p47 

    Background: Most cancers of the central nervous system (CNS) occur sporadically in the absence of any known underlying familial disorder or multi-systemic syndrome. Several syndromes are associated with CNS malignancies, however, and their recognition has significant implications for patient...

  • Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Shibamoto, Yuta; Sumi, Minako; Onodera, Shunsuke; Matsushita, Haruo; Sugie, Chikao; Tamaki, Yukihisa; Onishi, Hiroshi; Abe, Eisuke; Koizumi, Masahiko; Miyawaki, Daisuke; Kubota, Seiji; Ogo, Etsuyo; Nomiya, Takuma; Takemoto, Mitsuhiro; Harada, Hideyuki; Takahashi, Ippei; Ohmori, Yoshio; Ishibashi, Naoya; Tokumaru, Sunao; Suzuki, Kazunori // International Journal of Clinical Oncology;Oct2014, Vol. 19 Issue 5, p963 

    Background: The aim of our study was to analyze changes over time in the characteristics, treatment, and outcome of patients with primary central nervous system lymphoma (PCNSL). Methods: Data on 315 patients with histologically proven PCNSL undergoing radiotherapy between 2005 and 2009 were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics